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ABSTRACT  1 
Background: Early-life indoor bacterial exposure is associated with the risk of asthma but 2 
the roles of specific bacterial genera are poorly understood. 3 
Objective: To determine whether individual bacterial genera in indoor microbiota predict the 4 
development of asthma. 5 
Methods: Dust samples from living rooms were collected at 2months of age. The dust 6 
microbiota was characterized by Illumina MiSeq sequencing amplicons of bacterial 16S 7 
ribosomal RNA gene. Children (N=373) were followed up for ever asthma until the age of 8 
10.5 years.  9 
Results: Richness was inversely associated with asthma after adjustments (p=0.03). The 10 
phylogenetic microbiota composition in asthmatics’ homes was characteristically different 11 
from non-asthmatics’ homes (weighted UniFrac, adjusted association, PERMANOVA-S, 12 
p=0.02). The first two axis scores of principal coordinate nalysis of the weighted UniFrac-13 
distance matrix were inversely associated with asthma. Out of 658 genera detected in the dust 14 
samples, the relative abundances of 41genera correlated (r>|0.4|) with one of these axes. 15 
Lactococcus genus was a risk factor for asthma (aOR 1.36, 95%CI 1.13-1.63 per IQR 16 
change). The abundance of twelve bacterial genera (mostly from Actinomycetales order) was 17 
associated with lower asthma risk (p<0.10), though not independently of each other. The sum 18 
relative abundance of these12 intercorrelated genera was significantly protective and 19 
explained majority of the association of richness with less asthma.  20 
Conclusion: Our data confirms that phylogenetic differences in infant home microbiota are 21 
associated with subsequent asthma risk and suggest that communities of selected bacteria are 22 
more strongly linked to asthma protection than individual bacterial taxon or mere richness.  23 
 24 
Abstract word count: 247 25 
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Key messages 26 
• Childhood asthma risk is affected by bacterial compsition of the early-life home 27 
indoor microbiota.  28 
• Communities of bacteria, rather than an individual taxon or overall bacterial diversity, 29 
are most strongly linked to asthma protection. 30 
 31 
Capsule summary Early-life home indoor bacterial exposures are associated with the risk of 32 
asthma development. This study suggests that communities of protective environmental 33 
bacteria rather than individual taxon or overall bacterial diversity may offer asthma 34 
protection. 35 
  36 
Keywords (3-5): Asthma development, children, diversity, environment, Lactococcus  37 
Abbreviations:  38 
BLAST Basic Local Alignment Search Tool 39 
CE/m2 Cell Equivalents/square meter 40 
IQR Interquartile range 41 
MaAsLin Multivariate Association with Linear model  42 
NCBI National Center for Biotechnology Information 43 
OR   Odds ratio 44 
aOR adjusted Odds ratio 45 
OTU Operational Taxonomic Unit 46 
PASTURE Protection against Allergy Study in Rural Environments 47 
PCoA Principal Coordinate Analysis 48 
 49 
This article has an Online Repository at www.jacionline.org  50 
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Introduction 61 
Microbial exposures early in life may have a dual role in asthma development. Early -life 62 
viral infections predispose to asthma and also bacterial infections and airway colonization by 63 
potential respiratory bacterial pathogens may have similar influence.1 On the other hand it is 64 
well recognized that microbial exposure in utero and early life appear to be essential in 65 
instructing adaptive and regulated immune system responses to other environmental elements 66 
such as allergens, particles and viruses.2  67 
 68 
Accordingly, intimate exposure to environments rich in microbes, such as associated with 69 
traditional farming practices, may decrease the risk of asthma and other allergic diseases.3 The 70 
earlier epidemiologic studies on home microbial exposure and asthma were based on 71 
characterization of exposure through measures of general microbial markers4-7 such as 72 
endotoxin in dust samples (reviewed in ref.8). We have previously shown in this cohort that 73 
the quantity of exposure to bacterial and fungal cell wall components in early life has a bell-74 
shaped association with asthma at the age of 6 years.9 Studies with DNA based methods have 75 
indicated that the asthma protective characteristics may include diversity10-13 or more 76 
specifically diversity within certain taxon and lack of predisposing microbes.14-17 However, it 77 
remains unclear whether there are specific, individual taxa in indoor microbiome that are 78 
independently associated with reduced asthma risk. 79 
 80 
The overall objective of this study was to identify individual bacterial genera from the early-81 
life indoor environment that are associated with the development of asthma until the age of 82 
10.5 years. We also tested whether the protective association between high bacterial diversity 83 
and asthma is independent of the contributing microbes as has been hypothesized. 84 
 85 
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Methods 86 
The study population consisted of children born in M ddle and Eastern Finland: the first half 87 
of the study population (N=214) belongs to a European birth cohort (PASTURE)18 among 88 
farmers and non-farmers, while the second half of the cohort consists of unselected children 89 
(N=228).19 Pregnant women who gave birth between September 2002 and May 2005 were 90 
recruited. Selection procedure has been described earlier, and the study protocol was 91 
approved by a local ethics committee in Finland.19 Written informed consent was obtained 92 
from the parents.  93 
 94 
Follow-up 95 
The children were followed up with questionnaires19 as described in the Methods section in 96 
the Supplemental Material. ‘Ever asthma’ was defined as first parent-reported doctor-97 
diagnosed asthma and/or second diagnoses of asthmatic (or obstructive) bronchitis. ‘Current 98 
asthma’ was defined as ’ever asthma’ with  usage of asthma medication and/or reported 99 
wheezing symptom in the past 12 months at 10.5 year follow-up. Wheezing phenotypes were 100 
created using latent class analyses (see in the Supplemental Material). 101 
 102 
House dust samples  103 
House dust samples were sequenced from 394 living room floor dust samples. The protocols 104 
for dust collection of 2 months of age and analyzes of general microbial markers have been 105 
described previously.7,9 The protocol for sequencing (V4 region of the 16S rRNA),20data 106 
processing, and measuring the relative abundances and qPCRs (assay targeting the 16S rRNA 107 
gene) are described in the Methods section of Supplemental Material. Bacterial richness (a 108 
measure of the number of different Operational Taxonomic Units (OTU) in each sample) and 109 
Shannon diversity (abundance and evenness of the taxa in each sample) indices were 110 
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calculated within samples. The ‘load’ of the bacterial genus (i.e. expressed as cell equivalents 111 
per square meter (CE/m2)) was calculated by multiplying relative abundance with total 112 
bacteria(CE/mg) in that sample, as measured via qPCR  and with the amounts of dust, and 113 
dividing by sampling area(m2). 114 
 115 
Statistical analyses 116 
Statistical analyses are described in more detail in Supplemental Material. Generalized 117 
UniFrac based Principal Coordinate Analysis (PCoA) was performed using QIIME and the 118 
first six axes scores (Eigen values >1) were used in the analyses. The adjusted association of 119 
bacterial composition and ever asthma was studied using PERMANOVA-S.21  120 
 121 
T- or Kruskal-Wallis tests were used for comparing relative abundances of taxa in homes of 122 
asthmatics (ever asthma) and non-asthmatics children. For the multivariate models, the 123 
variables were ln-transformed (natural logarithm +1, except diversity indices) and divided by 124 
interquartile range (IQR). Discrete-time hazard models, generalized estimating equations, and 125 
multinomial logistic regression were used for analyzing asthma, respiratory symptoms and 126 
wheezing phenotypes, respectively. The results are presented as adjusted odds ratios (aORs) 127 
and their 95% confidence intervals (95%CI).  128 
 129 
In order to increase taxonomic resolution, oligotyping analysis was performed for 130 
Lactococcus genus using entropy positions.22 Multivariate association with linear models 131 
(MaAsLin)23 was run using all the most abundant taxa (mean reltiv  abundance >0.1%) from 132 
phylum to genus level. 133 
 134 
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All models were adjusted for follow-up time, study cohort, living on a farm and well-known 135 
risk factors for asthma (maternal history of allergic diseases, gender, number of older siblings, 136 
and smoking during pregnancy). Two selected models w re carefully tested for 25 additional 137 
confounding factors,7 but none of these potential confounders changed the estimates of 138 
exposure by >10%, and thus were not included in the analyses. At the age of 3 years, majority 139 
(80%) of the children still lived in the same house. The data were analyzed using SAS 9.3 for 140 
Windows (SAS Institute, Inc., Cary, NC).   141 
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Results 142 
Of the 442 children, 394 (89.1%) had data on the bacterial microbiota in dust samples and 373 143 
of those (94.6%) had sufficient data to assess asthma until the age of 10.5 years and 144 
information on covariates. By the age of 10.5 years, 69 children (18.5%) had developed ever 145 
asthma and 29 (7.8%) current asthma at 10.5years.  146 
 147 
Bacterial diversity in asthmatics’ and in non-asthmatics’ homes 148 
The bacterial richness and Shannon diversity index w re lower in the homes of children with 149 
ever asthma than in homes of non-asthmatics (Figure 1). When the models were adjusted for 150 
confounding factors, bacterial richness was inversely associated with ever asthma, and 151 
Shannon index qualified as a trend (Table I, p=0.03 and 0.12, respectively).  152 
 153 
UniFrac based weighted PCoA axis scores and asthma 154 
The overall microbiota composition between asthmatics and non-asthmatics was significantly 155 
different as indicated by weighted UniFrac beta-diversity analysis (adjusted association, 156 
PERMANOVA-S, p=0.02). The first two principal coordinate analyses axes scores (PCoA1 157 
and PCoA2) explained 36% of the variance in the weight d UniFrac dissimilarity distance 158 
matrix (Figure 2). The PCoA1 and PCoA2 axes scores were inversely associated with ever 159 
asthma (Table I). The first axis score appeared to reflect the ratio of Firmicutes and 160 
Proteobacteria in the samples with negative correlation with Firmicutes and positive 161 
correlation with Proteobacteria abundance at the phylum level. The second axis score 162 
appeared to reflect diversity and Actinobacteria abundance seen as positive correlation with 163 
both (Figure 3). The fourth most common phylum, Bacteroidetes, had a weak positive 164 
correlation with both axis scores (Figure 3). There were no significant associations between 165 
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the other four PCoA axis scores (Eigen value >1) and ever asthma (see Table E1 in the Online 166 
Repository).  167 
  168 
Phylum and genus levels in asthmatics’ and in non-asthmatics’ homes 169 
At the phylum level, the relative abundance of Firmicutes was higher and Actinobacteria was 170 
lower in the homes of asthmatic children than in the homes of non-asthmatics (see Figure E1 171 
in the Online Repository). At the genus level, the relative abundances of Lactococcus 172 
(Firmicutes) and Streptococcus (Firmicutes) were higher, but relative abundance of 173 
Sphingomonas (Proteobacteria) was lower in the homes of asthmatics than in the homes of 174 
non-asthmatics (Figure 4). Consistent with results on richness, the combined relative 175 
abundance of the rest of the genera (mean relative bundance < 1%) was lower in the homes 176 
of asthmatic children than in the homes of non-asthmatics (43.0% vs. 47.8%, respectively, 177 
p<0.001).  178 
 179 
Bacterial genera and asthma 180 
Out of detected 658 bacterial genera, 139 bacterial genera had the mean relative abundance 181 
greater than 0.1%, and they were further studied. Forty one of the 139 genera correlated (r 182 
|>0.4|) with either or both PCoA1 and PCoA2 axes scores (s e Table E2 in the Online 183 
Repository). After adjustments, the relative abundances of the 12 genera were inversely 184 
(p<0.1) and Lactococcus positively (p=0.001) associated with the development of ever 185 
asthma (Figure 5). Lactococcus (median relative abundance 3.9%) was the only genus that 186 
was associated with higher risk of ever asthma after correction for multiple testing 187 
(Bonferroni). High positive correlation coefficients (being mostly r=0.5 - 0.8) were found 188 
within the relative abundances of these 12 genera, except for Brevibacterium and other genus 189 
within Dermabacteraceae family, which had clearly lower correlation coefficients (see Figure 190 
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E2 and results in the Online Repository). When the negative associations of the 12 genera and 191 
the positive association of Lactococcus were mutually adjusted in the model of ever asthma, 192 
only the positive association of Lactococcus remained significant (see Figure E3 in the Online 193 
Repository).  194 
 195 
The relative abundances of the 12 protective genera w e thus added up into a new variable 196 
due to their high intercorrelation. The sum abundance of the 12 protective genera (median 197 
relative abundance 5.2%) was dose-dependently associ ted with ever asthma [compared to the 198 
lowest tertile, aOR 0.48 (95%CI 0.26, 0.85) for middle tertile p=0.01, and aOR 0.31 (95%CI 199 
0.15, 0.63) for highest tertile p=0.001]. The sum abundance of the12 protective genera and 200 
the Lactococcus genus were independent predictors for ever asthma (dat not shown). The 201 
associations with current asthma were largely similar (data not shown). 202 
 203 
The predisposing association between the relative abundance of Lactococcus, and the inverse 204 
association of the sum abundance of the 12 protective genera with ever asthma were 205 
independent of bacterial richness, Shannon index, amounts of dust, endotoxin, LPS10:0-16:0 and 206 
muramic acids (see Table E3 in the Online Repository). The sum abundance of the 12 207 
protective genera explained 61% of the association between richness and ever asthma (see 208 
Table E4 in the Online Repository). Environmental and behavioral determinants associated 209 
with reduced signals of asthma predisposing Lactococcus abundance and increase in asthma 210 
protection associated microbes included animal and f rm contacts, timber structures, age of 211 
the house and natural ventilation (see results and T ble E5 in the Online repository).   212 
 213 
Bacterial exposure and wheezing phenotypes 214 
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In the analyses of wheezing phenotypes (based on late t class analyses) during the first 6 215 
years of life, no associations were found between rlative abundance of Lactococcus, the sum 216 
abundance of the 12 protective genera, diversity indices and transient wheeze, which is 217 
mostly related to infections in early age (see Table E6 in the Online Repository). Even the 218 
number of cases in late onset and persistent wheeze groups were small, the associations were 219 
towards the same directions than with ever asthma, but they were clearly weaker. However, 220 
there were tendency of inverse associations between the sum of 12 protective genera and late 221 
onset and persistent wheeze (p<0.20). When exploring associations with respiratory 222 
symptoms, similar, but mostly non-significant, as with asthma ever associations were found, 223 
except for Lactococcus, which had weaker associations with wheezing (see Table E7 in the 224 
Online Repository).  225 
 226 
Oligotypes of Lactococcus and asthma 227 
In order to possibly increase taxonomic resolution for the finding of Lactococcus genus with 228 
ever asthma, oligotyping analysis was performed with this taxon, and 10 oligotypes were 229 
created (see Table E8 in the Online Repository). Most of the sequences belonged to the 230 
GGCCAAGGA oligotype (95% of all sequences), which had the highest mean relative 231 
abundance (7.2%) and correlated with the relative abundance of the Lactococcus genus and 232 
OTU number 1100972 (r=0.99). For this oligotype, two best BLAST hits from NCBI 233 
database were uncultured bacterial clone 1714 and L ctococcus lactis ubsp.(lactis gene for 234 
16S rRNA) with 100% similarity (identity and coverage). Relative abundances of each of the 235 
10 oligotypes were positively associated with the development of ever asthma after 236 
adjustments (p<0.15). The correlations between 10 oligotypes ranged from 0.28 to 0.70 237 
(mostly >0.45). When the relative abundances of 10 oligotypes were simultaneously adjusted, 238 
none of them were significantly associated with ever asthma (data not shown).  239 
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 240 
Loads of bacterial genera, total bacterial qPCR and asthma 241 
The associations with ever asthma were slightly weaker when the loads of the bacterial genera 242 
(i.e. expressed as cell equivalents per square meter (CE/m2)) were used instead of relative 243 
abundances, except for the Lactococcus genus, for which the estimate was stronger (see Table 244 
E9 in the Online Repository). The correlations between the relative abundances of sequences 245 
of the 13 bacterial genera and their loads were faily h gh (r= 0.57-0.79). Total bacterial 246 
qPCR was not associated with ever asthma or current asthma (data not shown).  247 
 248 
MaAsLin 249 
MaAsLin identified the relative abundance of 9 taxa th t were significantly associated with 250 
ever asthma after multiple testing was taken into account (Q-value <0.05). The strongest 251 
association was found with Lactococcus (see Table E10 in the Online Repository). For the 252 
rest taxa, other genus within Microbacteriaceae family, which was one of 12 protective 253 
genera, was also identified. 254 
  255 
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Discussion 256 
The present study suggests that phylogenetic differences in the early-home indoor microbiota 257 
composition precede asthma development and this associ tion is not explained by bacterial 258 
richness alone. Out of 658 genera detected in the dust samples, only the relative abundance of 259 
Lactococcus genus was determined as an independent risk factor for asthma. Twelve bacterial 260 
genera (mostly from Actinomycetales order) were identified as protective. The sum of the 261 
relative abundance of these 12 protective genera was significantly protective and explained 262 
majority of the association of richness with less athma.  263 
 264 
We found a similar inverse association between bacteri l richness and asthma, as have been 265 
reported in two recent cross-sectional studies from rural areas.10,12 Another nested case-266 
control study with high allergy risk children from urban environment, by Lynch and co-267 
workers, found similar association between bacterial richness and atopy and recurrent wheeze 268 
together with atopy, but not wheeze by itself at the age of 3 years.14 In contrast, a study 269 
among asthmatics showed that high levels of bacteril richness in homes was associated with 270 
more severe asthma symptoms compared to homes with lo  bacterial richness in house 271 
dust.24 This might be explained by the notion that bacterial richness may have different 272 
importance on asthma severity than on the development of asthma, something that has been 273 
found earlier with high endotoxin exposure.25 Thus, our findings support earlier observations 274 
that a diverse environmental microbial exposure at arly age via ingestion, inhalation and/or 275 
skin may be essential for stimulating immune development to respond appropriately to other 276 
environmental elements.2  277 
 278 
The phylogenetic composition of the microbiota was significantly different in house dust of 279 
asthmatics and non-asthmatics, as found with PERMANOVA-S analysis method that uses 280 
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UniFrac distance, a measure of similarity and dissimilarity of the bacterial composition 281 
between samples. Of the 12 protective genera that were identified, seven were from the 282 
Actinomycetales order, which are found in outdoor environmental sources (e.g. soil, fresh 283 
water and compost).The 12 genera were intercorrelated nd thus, it was not surprising that the 284 
individual genera were not associated with asthma protection independently from each other 285 
but their sum abundance was. Whether the 12 protective genera had a common source or 286 
distinct functional influence on asthma development, remains unclear. Interestingly, the 287 
association between bacterial richness and asthma was largely explained by the sum 288 
abundance of the 12 protective genera, but not with the low relative abundance of 289 
Lactococcus. This suggests that particular compositions of bacterial exposure, which source is 290 
outdoors, better predict the development of asthma than overall bacterial richness. However, 291 
the taxa that were identified and combined in the present study should be confirmed by other 292 
studies in different environments and in different geographical areas, and their potential 293 
protective functions should be explored. 294 
 295 
This study revealed a genus of gram-positive bacteria, Lactococcus (belonging to the 296 
Firmicutes phylum and Streptococcaceae family), which increased the risk of asthma 297 
independently of microbial diversity. Lactococcus is the most prevalent genus in raw and 298 
pasteurized cow’s milk,26 it is used in manufacturing of fermented dairy products and it is also 299 
found in soil. In the oligotyping analyses, the vast majority of the sequences of Lactococcus 300 
genus were allocated to one specific oligotype (GGCCAAGGA), which had the strongest 301 
effect on asthma development and which, based on the BLAST analyses, might refer to 302 
Lactococcus lactis. While there is a small but growing literature on early life environmental 303 
microbial exposures and development of wheeze and asthm  in children, no previous study 304 
has shown association with Lactococcus genus. A previous study27 found in a murine and 305 
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experimental model that exposure to Lactococcus lactis G121strain along with another 306 
bacterial strain, Acinetobacter lwoffii F78, which were both isolated from farm stables, 307 
prevented experimental allergic asthma in mice. The gram-positive L. lactis G121 especially 308 
activated cells through NOD2 and TLR2. In our study, we observed that the Lactococcus 309 
genus and its oligotypes were significant risk factors for asthma. Due to similar associations 310 
between Lactococcus genus and ever asthma among children from farms and non-farms, it is 311 
unlikely that farm milk is the source of Lactococcus genus in the present study. However, our 312 
sequencing analyses method was not designed to enter into the strains/species level with 313 
confidence, which is a general weakness of the amplicon sequencing method. Whether the 314 
Lactococcus genus is a true risk factor for asthma, or a proxy f other predisposing factor, e.g. 315 
particular life-style or nutrition, remains to be dtermined in experimental and other 316 
epidemiological studies including quantitative and specific detection (e.g. using qPCR) of 317 
Lactococcus. 318 
 319 
We have previously shown in this cohort that farm-like bacterial relative abundance patterns 320 
in indoor microbiota are associated with asthma protection by 6 years of age.15 There were 321 
little overlap between the specific genera identified n the current study to be associated with 322 
asthma after adjustment for farming and the best predictors of the farm-like indoor microbiota 323 
composition identified in our previous study. However, there were phylogenetic similarities 324 
as both imply importance of high abundance of members within the Actinobacteria phylum. 325 
In contrast, there was little or no overlap between the 13 genera identified in the present study 326 
and taxa that have been associated with lower asthm risk in other previous studies.10,12,14,16,17 327 
In these  studies, minimal10,12 to no14,16,17 adjustments have been made for potential 328 
confounders and comparability to our results is also influenced by other differences including 329 
those in sampling material, microbiological determinat ons, outcomes and study designs (e.g. 330 
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prospective vs. cross-sectional). A commonality in the present study and some of the previous 331 
studies has been that rather than diversity as such, it is certain compositional aspects within 332 
bacterial diversity that explain associations betwen indoor bacterial exposure and asthma.  333 
Further studies aiming at functional profiling e.g. by metagenomics, metabolomics or 334 
experimental studies are needed to characterize the potential asthma protective properties the 335 
bacterial taxa identified in here may have. 336 
 337 
Mechanisms behind the association between environmental microbial exposures in early life 338 
and asthma protection are not well understood. Evidence from epidemiological and 339 
experimental studies show that specific microbial exposures, such as those encountered in 340 
farming environment or homes with dogs, triggers receptors of the innate immunity,28 may 341 
increase epithelial barrier function in airways, presence of immunosuppressive cells, suppress 342 
responsiveness towards microbial immunogens and reduce allergen-induced airway 343 
inflammation.15,16,29,30 Exposure to rich and diverse microbiota may have a positive effect on 344 
airway colonization, which may in turn defend against viral infections and thus, contribute to 345 
the prevention of asthma.31,32 In addition, there is evidence from murine models that exposure 346 
to microbes in house dust modulates intestinal microb ota, and may, at least partially, mediate 347 
the effect on immune responses in airways.30,33 Whether this would also apply to humans 348 
remains unknown. There is evidence that environmental factors such as dogs can influence 349 
human gut microbiota composition,30,34 but overall this influence is thought to be limited.1 350 
   351 
In the present study, few environmental and behavior l determinants such as increased animal 352 
contacts, natural as opposed to mechanical ventilation nd timber structures were associated 353 
with reduced signals of asthma predisposing Lactococcus abundance and increase in asthma 354 
protection associated microbes. These and future findings from more focused studies could 355 
17 
 
 
direct public health initiatives for asthma preventio . Such initiatives may be efficient ways to 356 
reduce the allergy and asthma burden as indicated e.g. by the Finnish Allergy Program that 357 
provided practical recommendations also for behavior m dification.35 358 
 359 
The main strengths of the present study are the prospective birth cohort design with high 360 
participation rate and extensive set of microbial exposure measurements, including high 361 
resolution next generation sequencing data, DNA based targeted qPCR and general microbial 362 
markers. Dust samples were collected from living room floors at early childhood, which has 363 
shown to be an important time window for intensive maturation of the adaptive immunity.3 364 
Long-term active air sampling, which is the best way to assess exposure, is logistically and 365 
technically challenging in large cohorts, and, thus, surrogates of airborne microbial exposure 366 
are practically exclusively used.36 Floor dust better represents the overall environmental 367 
exposures carried from outdoors to indoors than, for example, bed dust that likely reflects also 368 
human associated microbiota.37 However, dust from floors/rugs will only be partially 369 
resuspended into the air with at a size that is inhalable and thus, only partially contribute to 370 
inhalation exposure. We have recently shown that microb ota of floor dust are not fully 371 
consistent with the microbiota of infant breathing zone air, but neither are the microbiota of 372 
bulk air in a room fully representative of the particular infant breathing exposure upon near 373 
floor activities.38 As noted earlier, oral ingestion exposure or exposure through the skin during 374 
the first years of life may be also relevant.2 One weakness of our study is that the taxonomic 375 
resolution of the sequencing approach did not, in ge eral, allow species levels identification. 376 
To overcome this restriction in taxonomic identification, future studies will have to 377 
implement metagenomics (shot-gun sequencing) approaches or more targeted approaches – 378 
such as qPCR or chip-based hybridization techniques – once knowledge on specific targets 379 
has accumulated.  380 
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 381 
In conclusion, our data confirms that phylogenetic differences in home microbiota influence 382 
asthma risk and suggest that communities of selected bacteria are more strongly linked to 383 
asthma protection than individual bacterial taxon or richness. 384 
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 525 
Table 526 
Table I. The associations between richness, Shannon index, the first two axes scores 527 
(PCoA1 and PCoA2) and the development of ever asthma until the age of 10.5 years and 528 
current asthma. 529 
 530 
 
Ever asthma Current asthma 
aOR (95%CI) p-value aOR (95%CI) p-value 
Richness 0.61 (0.39, 0.95) 0.03 0.55 (0.27, 1.12) 0.10 
Shannon index 0.77 (0.55, 1.07) 0.12 0.76 (0.45, 1.30) 0.32 
PCoA1 0.74 (0.57, 0.98) 0.03 0.76 (0.50, 1.16) 0.20 
PCoA2 0.75 (0.55, 1.02) 0.07 0.59 (0.36, 0.98) 0.04 
 531 
aOR Adjusted Odds Ratios; 95%CI 95% Confidence Intervals; aORs are expressed as 532 
interquartile range (IQR) change in the estimate (ln-transformed in axes scores); PCoA1 first 533 
axis score of weighted UniFrac based Principal Coordinate Analyses; PCoA2 the second axis 534 
score of weighted UniFrac based Principal Coordinate Analyses; Discrete-time hazard models 535 
are adjusted for follow-up time, cohort, living on a farm, gender, maternal history of allergic 536 
diseases, maternal smoking during pregnancy and number of older siblings. The number of 537 
subjects at the beginning of the survey/ the total number of observations in the analyses/ the 538 
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number of the outcome in ever asthma 373/2387/69 and in current asthma 310/2333/29 539 
models.  540 
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Figure legends 541 
Figure 1. Box-plots of A) bacterial richness and B) Shannon diversity index in homes of 542 
children with asthma ever (grey) and in homes of non-asthmatics’ children (white). 543 
Richness is the number of different OTUs in a sample. The boxplots present minimum, first 544 
quartile, median, third quartile, and maximum values. P-values are from T-test. 545 
 546 
Figure 2. Plot of PCoA1 and PCoA2 axes scores by ever asthma status. PCoA1 is the first 547 
and PCoA2 the second axis scores from weighted UniFrac based Principal Coordinate 548 
Analyses; children with ever asthma (red dots) and non-asthmatics (black dots); percentages 549 
of the variance explained by the axis scores are in the parentheses. Red and black ellipses 550 
represent 95%Confidence Intervals from T-test for children with ever asthma and non-551 
asthmatics children, respectively. 552 
 553 
Figure 3. Spearman Rank correlation coefficients between the first two axes scores, 554 
PCoA1 (light grey) and PCoA2 (dark grey), and four the most abundant bacterial phyla, 555 
richness and Shannon index. 556 
 557 
Figure 4. Relative abundances of the bacterial genera in living room dust (at age 2 558 
months) from homes of children A) with ever asthma and B) without asthma. The 641 559 
genera with mean relative abundance <1% in the whole dataset are combined in the sum 560 
variable. Phylum names are given in parenthesis. U. denotes “unassigned” and O. “other” 561 
genus within a family.*p-value <0.05 from Kruskal-Wallis test. 562 
 563 
Figure 5. Adjusted odds ratios (95% confidence intervals) between the selected 41 genera 564 
and asthma ever. Genera have been ordered by phylum. aORs are exprssed as interquartile 565 
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range (IQR) change in the estimate (ln-transformed). Models are adjusted for follow-up time, 566 
living on a farm, cohort, gender, maternal history f allergic diseases, maternal smoking 567 
during pregnancy and the number of older siblings. U. denotes “unassigned” and O. “other” 568 
genus within a family, and C. denotes Chloroflexi (phylum). 569 
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Figure E1. Relative abundances of the bacterial phyla in livi g room dust (at age 2 months) from 
homes of A) asthmatics and B) non-asthmatic children. The 26 phyla with mean relative abundance 
<1% in the whole dataset are combined into ‘rest 26 phyla’ category. *p-value <0.05 from Kruskal-
Wallis test. 
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Figure E2. Heat map of Spearman correlations between the relative abundances of 13 bacterial genera, amounts of dust, bacterial markers, 
qPCRs, richness and Shannon index.  
 
 
 
Figure E3. Mutually adjusted odds ratios (95% confidence intervals) between 13 taxa and ever 
asthma. Models are adjusted for follow-up time, living on a farm, cohort, gender, maternal history 
of allergic diseases, maternal smoking during pregnancy, the number of older siblings, and all 
genera simultaneously. U. denotes “unassigned” and O. “other” genus within a family. 
A=Firmicutes, B=Proteobacteria, C=Actinobacteria, D=Chloroflex. 
Axes scores
ǁ N
† N % aOR (95%CI) p -value
ǂ 
N
† N % aOR (95%CI) p -value
ǂ 
%
§
PCoA1
lowest tertile 127 817 3.9 1 108 806 1.7 1
middle tertile 124 798 2.6 0.70 (0.39, 1.25) 101 768 1.3 0.72 (0.31, 1.70)
highest tertile 122 772 2.1 0.57 (0.30, 1.08)^ 0.08 99 759 0.7 0.38 (0.13, 1.13) 0.07 25.99
PCoA2
lowest tertile 124 808 3.5 1 109 816 1.2 1
middle tertile 126 776 3.7 1.02 (0.59, 1.78) 101 750 1.7 1.19 (0.49, 2.87)
highest tertile 123 803 1.5 0.44 (0.21, 0.90)* 0.02 98 767 0.8 0.63 (0.21, 1.86) 0.39 10.56
PCoA3
lowest tertile 127 837 2.5 1 105 804 0.9 1
middle tertile 123 795 2.5 1.05 (0.56, 1.96) 104 794 1.3 1.51 (0.56, 4.05)
highest tertile 123 755 3.7 1.55 (0.86, 2.79) 0.14 99 735 1.6 1.72 (0.66, 4.85) 0.26 5.53
PCoA4
lowest tertile 119 761 3.2 1 101 761 1.5 1
middle tertile 128 836 2.8 0.94 (0.52, 1.70) 106 807 1.1 0.83 (0.34, 2.04)
highest tertile 126 790 2.8 1.01 (0.55, 1.85) 0.97 101 765 1.2 1.04 (0.42, 2.61) 0.93 4.67
PCoA5
lowest tertile 126 817 3.3 1 106 794 1.5 1
middle tertile 124 781 2.8 0.87 (0.48, 1.56) 101 766 1.3 0.86 (0.36, 2.08)
highest tertile 123 789 2.5 0.77 (0.42, 1.40) 0.39 101 773 0.9 0.58 (0.22, 1.54) 0.27 3.44
PCoA6
lowest tertile 126 771 3.6 1 102 759 1.7 1
middle tertile 124 820 1.8 0.50 (0.26, 0.95)* 103 797 0.8 0.52 (0.19, 1.39)
highest tertile 123 796 3.3 0.86 (0.49, 1.51) 0.60 103 777 1.3 0.79 (0.33, 1.87) 0.59 2.68
Table E1. The associations between the first six axes scores of weighted UniFrac based Principal Coordinate Analyses (PCoA) 
and the development of asthma ever until the age of 10.5 years and current asthma.
Current Asthma (n=29)Ever asthma (n=69)
ǁ
Axes scores are divided into tertiles, N† the number of subjects at the beginning of the survey; N the total number of 
observations in the analyses; % percentage of the outcome in the given group; aOR Adjusted Odds Ratios; 95%CI 95% 
Confidence Intervals; ǂp-value for linear trend test; §percentage of the component explained the variance in PCoA 
analyses. Models are adjusted for follow-up time, living on a farm, cohort, gender, maternal history of allergic diseases, 
maternal smoking during pregnancy, and the number of older siblings. p -value * <0.05, ^<0.1 .
class order family genus r
1
r
2 median
Interquartile 
range
MAX <DL
Firmicutes  (phylum)
Bacilli Bacillales Staphylococcaceae Staphylococcus -0.50 -0.08 5.17% (3.20, 8.50) 45.02% 0
Bacilli Lactobacillales Streptococcaceae Lactococcus -0.59 -0.24 3.94% (1.37, 10.01) 56.87% 0
Bacilli Lactobacillales Streptococcaceae Streptococcus 0.46 0.41 3.80% (1.77, 7.04) 62.47% 0
Clostridia Clostridiales Ruminococcaceae unassigned 0.01 0.41 0.20% (0.06, 0.72) 9.19% 15
Proteobacteria (phylum)
Alphaproteobacteria Caulobacterales Caulobacteraceae Mycoplana 0.46 0.41 0.14% (0.05, 0.28) 3.69% 19
Alphaproteobacteria Rhizobiales Hyphomicrobiaceae Devosia 0.43 0.41 0.12% (0.05, 0.24) 1.55% 13
Alphaproteobacteria Rhizobiales Rhizobiaceae Agrobacterium 0.42 0.30 0.17% (0.08, 0.30) 1.53% 8
Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas 0.45 0.12 2.08% (1.08, 3.99) 34.51% 0
Betaproteobacteria Burkholderiales Burkholderiaceae Burkholderia 0.15 -0.48 3.93% (1.55, 9.50) 58.27% 0
Betaproteobacteria Burkholderiales Comamonadaceae unassigned 0.47 0.26 0.39% (0.19, 0.67) 2.45% 0
Betaproteobacteria Burkholderiales Oxalobacteraceae unassigned 0.43 -0.16 1.82% (0.86, 3.21) 56.68% 0
Betaproteobacteria Burkholderiales Oxalobacteraceae Janthinobacterium 0.45 0.12 0.17% (0.07, 0.43) 3.80% 14
Gammaproteobacteria Xanthomonadales Xanthomonadaceae unassigned 0.40 0.25 0.19% (0.10, 0.33) 14.48% 4
Actinobacteria  (phylum)
Actinobacteria Actinomycetales unassigned unassigned 0.36 0.45 0.18% (0.09, 0.38) 5.46% 4
Actinobacteria Actinomycetales Brevibacteriaceae Brevibacterium 0.03 0.47 0.21% (0.08, 0.52) 6.79% 5
Actinobacteria Actinomycetales Dermabacteraceae Brachybacterium 0.11 0.50 0.20% (0.06, 0.58) 6.48% 12
Actinobacteria Actinomycetales Dermabacteraceae Dermatophilus 0.01 0.41 0.10% (0.04, 0.22) 4.29% 22
Actinobacteria Actinomycetales Dermabacteraceae other -0.03 0.46 0.10% (0.04, 0.18) 2.65% 15
Actinobacteria Actinomycetales Dietziaceae Dietzia 0.08 0.48 0.05% (0.02, 0.15) 1.14% 38
Actinobacteria Actinomycetales Intrasporangiaceae unassigned 0.27 0.45 0.16% (0.06, 0.34) 3.03% 10
Actinobacteria Actinomycetales Intrasporangiaceae other 0.28 0.50 0.17% (0.08, 0.35) 2.87% 4
Actinobacteria Actinomycetales Nakamurellaceae unassigned 0.43 0.32 0.08% (0.03, 0.21) 1.40% 24
Actinobacteria Actinomycetales Nocardioidaceae Nocardioides 0.43 0.30 0.07% (0.03, 0.18) 0.77% 24
Actinobacteria Actinomycetales Nocardioidaceae Aeromicrobium 0.41 0.43 0.06% (0.03, 0.14) 0.92% 27
Table E2. Description of relative abundances of 41 bacterial genera (sorted by phylum, class, order and family), which correlated either axis 
scores 1 or 2 (r  >|0.4|) in 394 dust samples. 
Actinobacteria Actinomycetales Nocardioidaceae unassigned 0.45 0.32 0.28% (0.11, 0.70) 3.04% 7
Actinobacteria Actinomycetales Nocardioidaceae Rhodococcus 0.43 0.40 0.09% (0.04, 0.17) 1.37% 10
Actinobacteria Actinomycetales Microbacteriaceae unassigned 0.44 0.43 0.16% (0.06, 0.32) 2.06% 7
Actinobacteria Actinomycetales Microbacteriaceae other 0.40 0.46 0.10% (0.04, 0.17) 1.46% 12
Actinobacteria Actinomycetales Microbacteriaceae Cryocola 0.44 0.38 0.07% (0.03, 0.17) 1.37% 24
Actinobacteria Actinomycetales Microbacteriaceae Frigoribacterium 0.43 0.37 0.11% (0.05, 0.25) 1.94% 17
Actinobacteria Actinomycetales Microbacteriaceae Salinibacterium 0.44 0.43 0.09% (0.03, 0.21) 1.97% 20
Actinobacteria Actinomycetales Micrococcaceae unassigned 0.25 0.56 0.48% (0.22, 0.94) 7.40% 2
Actinobacteria Actinomycetales Micrococcaceae Arthrobacter 0.35 0.46 0.11% (0.04, 0.34) 3.22% 14
Actinobacteria Actinomycetales Micrococcaceae Kocuria 0.01 0.49 1.08% (0.51, 2.03) 18.63% 0
Actinobacteria Actinomycetales Mycobacteriaceae Mycobacterium 0.41 0.34 0.09% (0.04, 0.17) 1.02% 13
Bacteroidetes  (phylum)
Cytophagia Cytophagales Cytophagaceae Dyadobacter 0.43 0.40 0.07% (0.02, 0.17) 0.97% 26
Cytophagia Cytophagales Cytophagaceae Hymenobacter 0.42 0.22 0.37% (0.13, 0.86) 3.69% 1
Flavobacteriia Flavobacteriales Flavobacteriaceae Flavobacterium 0.44 0.30 0.24% (0.09, 0.58) 13.26% 11
[Saprospirae] [Saprospirales] Chitinophagaceae unassigned 0.40 0.30 0.16% (0.06, 0.33) 2.01% 14
Sphingobacteriia Sphingobacteriales Sphingobacteriaceae Pedobacter 0.49 0.31 0.44% (0.16, 0.93) 14.40% 5
Chloroflexi  (phylum)
Thermomicrobia JG30-KF-CM45 unassigned unassigned 0.31 0.49 0.10% (0.04, 0.24) 3.81% 11
r
1
 Spearman's correlations with axis score 1 (PCoA1), r
2
 Spearman correlations with axis score 2 (PCoA2), median relative abundance (median), 
25
th
 and 75
th
 percentile of relative abundance (Interquartile range), maximum value of the relative abundance (MAX) and the number of 
samples under detection limit (DL). 
Richness Shannon index Amount of dust Endotoxin LPS 10:0-16:0 Muramic acids
aOR (95%CI) aOR (95%CI) aOR (95%CI) aOR (95%CI) aOR (95%CI) aOR (95%CI) aOR (95%CI)
Lactococcus 1.36 (1.13, 1.63) 1.29 (1.06, 1.58) 1.35 (1.08, 1.67) 1.32 (1.09, 1.59) 1.42 (1.16, 1.75) 1.36 (1.13, 1.64) 1.36 (1.10, 1.69)
The sum of 12 
protective genera 0.50 (0.32, 0.79) 0.53 (0.30, 0.96) 0.50 (0.30, 0.85) 0.53 (0.33, 0.84) 0.52 (0.32, 0.86) 0.54 (0.34, 0.86) 0.63 (0.40, 1.00)
Ever asthma
Table E3. Associations between relative abundance of Lactococcus, sum of 12 protective genera and ever asthma additionally adjusted for bacterial diversity 
indices, amount of dust, endotoxin, LPS and muramic acids.
Models are adjusted for follow-up time, living on a farm, cohort, gender, maternal history of allergic diseases, maternal smoking during pregnancy, and 
the number of older siblings, and additionally for diversity indices (continues), amount of dust and general microbial markers (units/m
2
 in tertiles); 
aOR Adjusted Odds Ratios; 95%CI 95% Confidence Intervals; aORs are expressed as IQR change in the estimate (ln-transformed). 
Additionally adjusted for
Lactococcus
The sum of 12 
protective genera
aOR (95%CI) aOR (95%CI) aOR (95%CI)
Richness 0.61 (0.39, 0.95) 0.74 (0.46, 1.19) 0.91 (0.49, 1.69)
Shannon index 0.77 (0.55, 1.07) 0.97 (0.65, 1.45) 0.99 (0.66, 1.50)
Table E4. Associations between bacterial richness, Shannon index and ever asthma 
additionally adjusted for relative Lactococcus and the sum of 12 protective genera.
Additionally adjusted for
Ever asthma
Models are adjusted for follow-up time, living on a farm, cohort, gender, maternal 
history of allergic diseases, maternal smoking during pregnancy, and the number of 
older siblings; aOR Adjusted Odds Ratios; 95%CI 95% Confidence Intervals; aORs are 
expressed as IQR change in the estimate.
N % p-value
1 cOR (95%CI) p-value
2 % p-value
1 cOR (95%CI) p-value
2
Living on a farm, no (ref.) 278 57.2 1 40.7 1
yes 116 32.8 <0.0001 0.36 (0.23, 0,57) <0.0001 72.4 <0.0001 3.83 (2.39, 6.15) <0.0001
N % p-value
1 aOR (95%CI) p-value
2 % p-value
1 aOR (95%CI) p-value
2
Construction year, before 1970 (ref.) 127 30.7 1 69.3 1
1970-1989 135 61.5 2.98 (1.75, 5.06) <0.0001 43.7 0.45 (0.26, 0.77) 0.003
after 1989 115 58.3 <0.0001 2.39 (1.37, 4.19) 0.002 36.5 <0.0001 0.37 (0.21, 0.66) 0.001
Floors,  1 (ref.) 230 55.2 1 45.2 1
≥2 147 42.2 0.01 0.68 (0.44, 1.05) 0.08 57.8 0.02 1.39 (0.90, 2.16) 0.14
Basement, no (ref.) 264 56.8 1 44.3 1
yes 113 34.5 <0.0001 0.54 (0.33, 0.88) 0.01 63.7 0.001 1.42 (0.86, 2.34) 0.17
Ground, slab (ref.) 329 52.9 1 45.9 1
other 48 31.3 0.005 0.54 (0.27, 1.06) 0.07 79.2 <0.0001 3.28 (1.54, 7.00) 0.002
Log frame, timber (ref.) 319 48.6 1 54.6 1
brick/ concrete 58 58.6 0.16 1.19 (0.66, 2.13) 0.56 25.9 <0.0001 0.37 (0.19, 0.71) 0.003
Exterior wall (siding) material
timber (ref.) 236 46.6 1 57.2 1
brick 119 59.7 1.51 (0.95, 2.39) 0.08 39.5 0.55 (0.35, 0.88) 0.01
other 22 36.4 0.03 0.59 (0.23,  1.49) 0.27 31.8 0.002 0.36 (0.13, 0.94) 0.04
Ventilation, natural (ref.) 165 39.4 1 63.0 1
mechanical exhaust ventilation (from 
kitchen/bathroom) 137 60.6 1.92 (1.18, 3.11) 0.01 38.7 0.47 (0.29, 0.78) 0.003
house-specific mechanical supply and 
exhaust ventilation 75 54.7 0.001 1.49 (0.84, 2.64) 0.17 42.7 <0.0001 0.57 (0.32, 1.03) 0.06
Heating with wood, no (ref.) 80 57.5 1 22.5 1
yes, occasionally 40 47.5 0.96 (0.43, 2.13) 0.91 62.5 3.94 (1.67, 9.31) 0.002
Supplemental Table E5. Determinants of relative abundance of Lactococcus  genus and the sum of 12 protective genera.  
Lactococcus (>median) Sum of 12 protective genera (>median)
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yes, regularly 250 46.8 0.24 0.84 (0.43, 1.43) 0.53 55.6 <0.0001 3.25 (1.78, 5.91) 0.0001
Having dog(s) and keeping indoors
no dog/ never indoors (ref.) 261 56.7 1 42.5 1
sometimes/often indoors 40 50.0 1.08 (0.53, 2.19) 0.84 77.5 3.53 (1.57, 7.96) 0.002
mostly indoors 88 30.7 0.0001 0.32 (0.19, 0.55) <0.0001 61.4 <0.0001 2.24 (1.34, 3.74) 0.002
Having cat(s) and keeping indoors
no cat/ never indoors (ref.) 301 55.2 1 47.8 1
sometimes/often indoors 30 26.7 0.46 (0.19, 1.13) 0.09 60.0 0.73 (0.29, 1.65) 0.41
mostly indoors 62 35.5 0.001 0.55 (0.31, 1.00) 0.05 56.5 0.25 0.94 (0.52, 1.72) 0.85
Number of pet species (dog,cat,rabbit,turtle, rodents, fish,bird)
0 (ref.) 154 66.2 1 31.8 1
1 162 44.4 0.46 (0.29, 0.74) 0.001 58.0 2.43 (1.51, 3.91) 0.0003
2-6 78 29.5 <0.0001 0.29 (0.15, 0.57) 0.0003 69.2 <0.0001 2.82 (1.46, 5.45) 0.002
Contact with horses during first trimester
never/seldom (ref.) 350 50.9 1 46.9 1
monthly/weekly 24 41.7 0.76 (0.32, 1.80) 0.53 79.2 4.15 (1.48, 11.65) 0.007
daily 20 45.0 0.62 1.32 (0.50, 3.44) 0.57 70.0 0.002 1.47 (0.52, 4.16) 0.47
Last vacuumed (days), 0-1 (ref.) 142 48.6 1 53.5 1
2-3 114 42.1 0.68 (0.41, 1.13) 0.14 52.6 1.12 (0.67, 1.88) 0.67
≥4 138 58.0 0.04 1.20 (0.73, 1.95) 0.48 44.2 0.24 0.89 (0.54, 1.47) 0.66
Median levels are used as a cut-off values for define high levels of exposure; N Total number of observations in given class; % percentage of 
the high (>median) level of the sum of relative abundances of 12 genera in given class; p - value
1
 p -values are from X
2
 test; cOR (95%CI) 
crude odds ratio (farming vs. Lactococcus  or the sum of 12 genera) and its confidence intervals; p -value
2
 p -values are from logistic 
regression models.  aOR (95%CI) adjusted odds ratios and its confidence intervals; the models are adjusted for farming; ref. denotes refrence 
category.
C:\pdfconversion\WORK\authordoc\Supplemental_Tables_E1_E10_unmarked_R2.xlsx 13-08-2019
aOR (95%CI)
p-
value aOR (95%CI)
p-
value aOR (95%CI)
p-
value aOR (95%CI)
p-
value
Lactococcus 1.02 (0.78, 1.33) 0.90 0.88 (0.44, 1.77) 0.72 1.19 (0.71, 1.99) 0.52 1.14 (0.75, 1.72) 0.54
The sum of 12 protective genera 1.05 (0.73, 1.50) 0.81 0.84 (0.31, 2.28) 0.73 0.46 (0.15, 1.45) 0.18 0.57 (0.25, 1.32) 0.19
Richness 1.14 (0.69, 1.89) 0.61 0.86 (0.26, 2.83) 0.80 0.68 (0.21, 2.17) 0.51 0.87 (0.36, 2.07) 0.75
Shannon index 0.96 (0.64, 1.45) 0.84 1.21 (0.42, 3.46) 0.73 0.80 (0.33, 1.98) 0.64 0.90 (0.45, 1.81) 0.78
Table E6. Adjusted associations between relative abundance of Lactococcus , the sum of 12 protective genera, diversity indices, and wheezing 
phenotypes. 
Transient wheeze Intermediate wheeze Late onset wheeze Persistent wheeze
The total number of observations in the analyses 322; Never/infrequent wheeze was used as a reference group, n=201 (62.4%); Transient 
wheeze, n=77 (23.9%); Intermediate wheeze, n=12 (3.7%); Late onset wheeze, n=11  (3.0%); Persistent wheeze, n=21  (6.5%); aOR Adjusted 
Odds Ratios; 95%CI 95% Confidence Intervals; aORs are expressed as IQR change in the estimate; Multinomial logistic regression models are 
adjusted for cohort, living on a farm, gender, maternal history of allergic diseases, maternal smoking during pregnancy and the number of older 
siblings. 
N/n aOR (95%CI) p-value N/n aOR (95%CI) p-value N/n aOR (95%CI) p-value
2716/213 2736/462 2711/475
Lactococcus 1.02 (0.84, 1.24) 0.84 1.07 (0.92, 1.24) 0.39 1.12 (0.98, 1.28) 0.10
The sum of 12 protective genera 0.71 (0.51, 0.99) 0.04 0.79 (0.64, 0.99) 0.04 0.86 (0.69, 1.07) 0.17
Richness 0.85 (0.56, 1.27) 0.42 0.89 (0.66, 1.20) 0.43 0.87 (0.65, 1.16) 0.34
Shannon index 0.90 (0.67, 1.20) 0.46 0.95 (0.76, 1.20) 0.69 0.88 (0.69, 1.12) 0.29
Wheezing without cold Any wheezing
Nocturnal cough wihout 
cold
N total number of observations in the analyses; n total number of symptoms; Models are adjusted for follow-up time, living on a 
farm, cohort, gender, maternal history of allergic diseases, maternal smoking during pregnancy, and the number of older siblings; 
aOR Adjusted Odds Ratios; 95%CI 95% Confidence Intervals; aORs are expressed as IQR change in the estimate. 
Table E7. Associations between relative abundance of Lactococcus  genus, the sum of 12 protective genera, bacterial richness, Shannon 
index and respiratory symptoms.
Oligotype¤
number of 
sequences
mean 
relative 
abundance
<DL aOR (95%CI) p -value aOR (95%CI)
p -
value 
GGCCAAGGA 355,480 0.07240 1 1.33 (1.12, 1.58) 0.001 1.20 (0.92, 1.58) 0.17
ATACCATGA 9,241 0.00188 22 1.12 (0.96, 1.31) 0.14 1.18 (0.91, 1.52) 0.15
GGCTAGGGA 2,042 0.00043 108 1.13 (1.03, 1.23) 0.006 1.06 (0.92, 1.21) 0.41
GGCCAAGGG 1,790 0.00038 88 1.25 (1.11, 1.41) 0.0003 1.31 (1.08, 1.57) 0.005
ATACAATGA 1,741 0.00036 110 1.10 (0.98, 1.22) 0.10 1.14 (0.98, 1.31) 0.08
GGTCAGGGG 1,511 0.00033 155 1.08 (1.03, 1.14) 0.002 1.21 (1.06, 1.37) 0.004
GGCCAAGTA 1,124 0.00024 149 1.07 (1.00, 1.15) 0.05 1.05 (0.94, 1.17) 0.37
GGCCAATGA 1,102 0.00023 155 1.14 (1.03, 1.25) 0.008 1.10 (0.95, 1.27) 0.21
GGCCAGGGA 992 0.00021 134 1.25 (1.11, 1.41) 0.0003 1.21 (1.02, 1.43) 0.03
GGTCAGGGA 815 0.00017 172 1.15 (1.03, 1.29) 0.015 1.19 (1.01, 1.40) 0.04
Table E8. Associations between relative abundances of Lactococcus  oligotypes and the development of 
asthma.
Models are adjusted for follow-up time, living on a farm, cohort, gender, maternal history of allergic 
diseases, maternal smoking during pregnancy, and the number of older siblings; aOR Adjusted Odds 
Ratios; 95%CI 95% Confidence Intervals, ORs are expressed as IQR change in the estimate (ln-
transformed relative abundance); ¤ Letters referes to nucleotides in 68, 127, 208, 209, 213, 220, 241, 
243, 245 positions.  Significant results (p<0.05) are in boldface. 
Current asthmaEver asthma 
Bacterial genus aOR (95%CI)
p -
value aOR (95%CI)
p -
value 
Lactococcus 1.36 (1.13, 1.63) 0.001 1.49 (1.03, 2.16) 0.03
Sphingomonas 0.74 (0.53, 1.05) 0.09 0.77 (0.56, 1.06) 0.11
Janthinobacterium 0.75 (0.55, 1.01) 0.06 0.90 (0.72, 1.10) 0.28
Brevibacterium 0.71 (0.48, 1.04) 0.08 0.81 (0.61, 1.08) 0.16
Dermabacteraceae O. 0.74 (0.53, 1.02) 0.07 0.85 (0.70, 1.02) 0.09
Nocardioides 0.59 (0.40, 0.89) 0.01 0.87 (0.73, 1.03) 0.10
Nocardioidaceae U. 0.64 (0.44, 0.94) 0.02 0.81 (0.64, 1.02) 0.07
Microbacteriaceae U. 0.66 (0.44, 0.97) 0.04 0.85 (0.68, 1.08) 0.18
Microbacteriaceae O. 0.63 (0.43, 0.93) 0.02 0.81 (0.66, 0.99) 0.04
Salinibacterium 0.76 (0.56, 1.04) 0.09 0.82 (0.69, 0.98) 0.03
Micrococcaceae U. 0.60 (0.38, 0.94) 0.03 0.85 (0.64, 1.13) 0.26
Mycobacterium 0.71 (0.50, 1.03) 0.07 0.87 (0.72, 1.04) 0.13
Chitinophagaceae U. 0.76 (0.57, 1.03) 0.08 0.88 (0.71, 1.08) 0.22
Table E9. Associations between relative abundances or loads of 13 bacterial 
genera and ever asthma.
Ever asthma
Load of a bacterial genus (CE/m
2
) was calculated by multiplying relative 
abundance with total bacterial load measured via qPCR in a sample; aOR 
Adjusted Odds Ratios; 95%CI 95% Confidence Intervals; aORs are expressed as 
IQR change in the estimate (ln-transformed relative abundance or CE/m
2
); U 
denotes 'unassigned' and O denotes 'other' genus within family; Models are 
adjusted for follow-up time, living on a farm, cohort, gender, maternal history 
of allergic diseases, maternal smoking during pregnancy, and the number of 
older siblings; Significant results (p<0.05 ) are in boldface. 
Relative abundance Load (CE/m
2
)
Variable Feature
Valu
e
Coeffici-
ent N N.not.0 P. value Q. value
asthma_ever k_Bacteria_p_Firmicutes_c_Bacilli_o_Lactobacillales_f_Streptococcaceae_g_Lactococcus 1 0.08480 394 394 0.00001 0.00034
asthma_ever k_Bacteria_p_Firmicutes_c_Bacilli_o_Lactobacillales_f_Streptococcaceae 1 0.07675 394 394 0.00015 0.00289
asthma_ever k_Bacteria_p_Proteobacteria_c_Betaproteobacteria_o_Burkholderiales_f_Comamonadaceae_g_Roseateles 1 -0.00348 394 176 0.00046 0.00790
asthma_ever k_Bacteria_p_Proteobacteria_c_Alphaproteobacteria_o_Rhizobiales_f_Hyphomicrobiaceae_g_Rhodoplanes 1 -0.00415 394 248 0.00090 0.01396
asthma_ever k_Bacteria_p_Firmicutes 1 0.06472 394 394 0.00117 0.01772
asthma_ever k_Bacteria_p_Actinobacteria_c_Actinobacteria_o_Actinomycetales_f_Microbacteriaceae_g_Other 1 -0.00603 394 382 0.00329 0.04267
asthma_ever k_Bacteria_p_Chloroflexi_c_Chloroflexi 1 -0.00468 394 256 0.00339 0.04359
asthma_ever k_Bacteria_p_Bacteroidetes_c_Rhodothermi_o_Rhodothermales_f_Rhodothermaceae_g_Rubricoccus 1 -0.00252 394 148 0.00352 0.04494
asthma_ever k_Bacteria_p_Proteobacteria_c_Alphaproteobacteria_o_Rhizobiales_f_Bradyrhizobiaceae_g_Unassigned 1 -0.00568 394 389 0.00386 0.04866
Variable= ever asthma until the age of 10.5 years, Feature= the taxonomic hierarchical level of the given taxa; Value= asthma ever vs no asthma, Coefficient=coefficient of the asthma ever and 
given taxa in the linear model; N the total number of samples; N.not.0= the number of samples, which relative abundance is above detection limit; P.value= p-value for linear association; Q-
value=multiple testing corrections with Benjamini and Hochberg (BH) procedure.   
Table E10. Top 9 of the results (Q value <0.05) of MaAsLin analysis with bacterial/archaeal taxa and ever asthma. 
1 
 
Online Repository materials 
Indoor Bacterial Microbiota and the Development of Asthma by 10.5 years of age 
Anne M. Karvonen, PhD, Pirkka V. Kirjavainen, PhD, Martin Täubel, PhD, Balamuralikrishna 
Jayaprakash, MSc, Rachel I. Adams, PhD, Joanne E. Sordillo, ScD, Diane R. Gold, MD, MPH, 
Anne Hyvärinen, PhD, Sami Remes, MD,MPH, Erika von Mutius, MD, and Juha Pekkanen, MD 
 
Contents 
2 Methods ........................................................................................................................................................... 2
3 Results ........................................................................................................................................................ 8
 
 
 
  
2 
 
2 Methods  
Follow-up 
The first questionnaire was administered during the third trimester of pregnancy.E1 The follow-up 
questionnaires (2, 12, 18 and 24 months old, and thereafter annually until the age of 6 years and 
then at the age of 10.5 years), except the questionna re at two months, enquired about respiratory 
symptoms, doctor diagnosed asthma and asthmatic (obstructive) bronchitis, usage of medication 
and confounders for the time period after the preceding questionnaire and previous 12 months. 
‘Ever asthma’ was defined as first parent-reported doctor-diagnosed asthma and/or second 
diagnoses of asthmatic (or obstructive) bronchitis. ‘Current asthma’ was defined as ‘ever asthma’ 
with usage of asthma medication and/or reported wheezing symptom in the past 12 months at 10.5-
year follow-up. Among non-asthmatics, one missing follow-up was accepted and coded as no 
disease (n=25), if parents had answered all the remaining follow-up questionnaires and in the 6 
and/or 10.5yrs’ questionnaires they reported that teir child had not had asthma and/or asthmatic 
bronchitis ever in life. Other children were excluded from the analyses. In total, 373 and 310 
children had information on outcome, confounders and sequencing data and thus, were included 
into the ever asthma and current asthma models, respectively.  
  
House dust sample  
The protocol for dust collection of the age of 2 months has been explained in detail previously.E2 
Briefly, in the Finnish PASTURE study, fieldworkers took a sample from living room floors for the 
present report, while in the extended cohort, parents collected the floor dust. The samples were 
processed and analyzed at National Institute for Health and Welfare (THL), where they were sieved 
to remove larger particles, dried, split and then stored at -80ºC before analyses. 
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Sequencing 
Genomic DNA was extracted from 20mg of dust using bead beating method and chemagic DNA 
plant kit (Perkin Elmer) on the KingFisher DNA extraction robot. The extracted DNA was stored at 
-80⁰C and shipped to the sequencing laboratory on dry ice. LGC Genomics (Germany) did the 
library preparation and sequencing. The V4 region of the 16S marker was amplified using 
515F/806R primers.E3 This primer set amplifies not only bacterial, but also archaeal taxa; however, 
the latter at limited phylogenetic coverage.E4 Thus, we refer in the text mostly to ‘bacterial’, rather 
than to ‘bacterial/archaeal’ sequencing/microbiota, even if both kingdoms were at least partially 
covered. Amplicons were sequenced with 300 base pair paired-end reads using Illumina’s MiSeq 
V3 chemistry.  
 
Individual samples with a low read number after sequencing were re-sequenced (n=148). Sequences 
of two re-sequenced samples were used instead of the riginal sequences as the number of reads in 
the original sequencing efforts were below the rarefaction value of 2,150 sequences.  
 
LGC Genomics performed preprocessing with the following steps. Demultiplexing relied on the 
bcl2fastq software provided by Illumina. Inline barcode sorting/clipping, adapter clipping, and 
primer detection/clipping steps relied on in-house scripts by LGC Genomics. Forward and reverse 
reads were merged using FLASH.E5 After this preprocessing, the vast majority of reads were 
retained (mean 96.9%).  All subsequent analysis relied on QIIME.E6 Sequences were quality filtered 
using the split_libraries_fastq.py command with a mini um quality score of 20. Chimeric 
sequences were identified using usearch 61 algorithmE7 and excluded. Sequences were clustered 
into Operational Taxonomic Units (OTUs) at 97% similarity using the open-reference OTU picking 
strategyE8 with 100% subsampling of those sequences that failed to cluster to greengenes 
database.E9 OTUs representing less than 0.001% of the total sequences (minimum count of 83 
4 
 
sequences) were excluded. Chloroplast (n=93) and mitochondrial (n=23) sequences were removed 
from the bacteria OTU table. Tree building used pynast to align sequences,E10 and the resulting 
alignment was filtered to remove gaps prior to building a phylogeny using the fasttree method. 
 
In total, 4,248 bacterial OTUs were identified at the 97% clustering approach, comprised of 658 
different bacterial genera in 394 dust samples in bacterial data. Relative bacterial richness (a 
measure of the number of OTUs) in each sample (rarified to 2,150) and Shannon diversity 
(abundance and evenness of the taxa in each sample) indices were calculated within samples. 
Abundance weighted and unweighted UniFrac distance between samples, a measure of 
phylogenetic similarity and dissimilarity between samples based on their bacterial community 
composition, was calculated in QIIME.E11 Beta diversity calculations based on UniFrac metrics 
were calculated between samples using beta_diversity.py script available in QIIME. Both alpha and 
beta diversity calculations were calculated at the same rarefaction value of 2,150. 
  
Relative abundance and load of taxa 
The average (SD) number of raw reads across all samples was 12,876 (mean ± SD = 12,876 ± 
5,223). The measurements of bacteria were based on relative abundance i.e. the percentage of reads 
of a taxon per the total reads in a sample. The 139 bacterial genera with mean relative abundances 
of greater than 0.1%, were used in the analyses of a thma.  
 
Total bacterial biomass was calculated from the sumof gram negative and gram positive bacteria 
using a previously developed qPCR assayE12 and was expressed as total bacterial concentration in 
the samples (cell equivalents (CE) per mg of dust). The amount of total bacteria and taxa were also 
expressed as loads, i.e. the cell equivalents per square meter of sampling surface (CE/m2). The 
’genus load’ was calculated by multiplying the relative abundance with total bacteria (CE/mg) in 
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that sample, as measured via qPCR  and with the amounts f dust, and dividing by sampling area 
(m2).  
 
General microbial markers 
Earlier analyzed bacterial biomass or cell-wall comp nentsE2 (general microbial markers: endotoxin 
and LPS10:0-16:0 for gram-negative bacteria; muramic acid for gram-positive bacteria) and amount of 
dust from the 2 months dust samples were used for testing whether the identified taxa were 
independent predictors for asthma adjusting models additionally with these markers. 
 
Oligotyping for Lactococcus genus  
Oligotyping analysisE13 of Lactococcus genus (375,838 reads; 98.0% of all reads analyzed) was 
performed using 10 entropy positions (nucleotides in 68, 127, 208, 209, 213, 220, 241, 243, 245 
positions). Total purity score of the analysis was 0.92. Most of the reads (355,480 reads) belonged 
to the GGCCAAGGA –oligotype. BLAST hits from the NCBI library was performed using 
accession numbers (December 1st, 2016). Relative abundances of individual oligotypes were 
calculated by multiplying the relative abundance of Lactococcus genus by the percentage of an 
oligotype divided by 100.        
  
Wheezing phenotypes 
 Wheezing phenotypes were based on the repeated parent-reported any wheezing until the age of 6 
years. Due the respective time period varied between qu stionnaires, each follow-up period was 
recoded to cover 12 months. Only those who had the maximum of one missing information on 
wheezing, were included into the analyses. Firstly, the wheezing phenotypes were estimated using 
latent class analyses (LCA)E14 in the whole PASTURE cohort (N=953)E15 where the first half of the 
study population belongs. Then, LCA was rerun with children from the Finnish extended cohort 
(N=185), which gave us similar wheezing patterns as een by Depner et al.E15 The correlations 
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between two LCAs were high. Five phenotypes were created: Never/ Infrequent wheeze, which was 
used as a reference category, Transient, Infrequent, Late onset and Persistent wheeze.      
 
Statistical analyses 
UniFrac, a measure of similarity and dissimilarity between samples based on their bacterial 
composition, was calculated based on the abundance (‘weighted’) of individual bacterial OTUs, 
including also their phylogenetic relatedness.E11 For community data, Generalized UniFrac at an 
alpha of 1.0 based Principal Coordinate Analysis (PCoA), which takes into account phylogenetic 
relatedness of the biological community, was performed using QIIME and the first 6 axes scores 
were analyzed (Eigen values >1). The adjusted association of bacterial composition and ever 
asthma was studied using PERMANOVA-S.E16 Spearman’s correlations were calculated. 
Multinomial logistic regression was used for analyses of wheezing phenotypes. 
 
In the multivariate models, the ln-transformed (natur l logarithm+1) divided by interquartile range 
(IQR) variables of the exposure were used, except alpha-diversity metrics. In addition, variables 
were divided into three groups using the tertile as cut-offs.  
 
Survival analyses (discrete-time hazard models) were used in analyzing ever asthma and current 
asthma. Generalized estimating equations (GEE) with an exchangeable correlation structure to 
account for correlation between repeated measures within subjects, were used to determine 
associations between different genera and repeated measures of parent-reported wheezing and 
cough at different ages. The results are presented as a justed odds ratios (aORs) and their 95% 
confidence intervals (95%CI).  
 
7 
 
Multivariate association with linear models (MaAsLin)E17 was run using all the most abundant taxa 
(mean relative abundance >0.1%) from phylum to genus level. Models were performed using 
defaults, which include for example arcsine square root transformation, Grubbs’ test for outliers 
test, multiple testing corrections with Benjamini ad Hochberg (BH) procedure and feature boosting 
in order simplify models. The boosting refers to the inclusion of confounders (all the variables that 
were used in the asthma models in the present study) that are prior tested and selected into the 
model with a given taxon, if they showed any potential association with the given microbial taxon.      
   
All models were adjusted for time of follow-up, study cohort, living on a farm and well-known risk 
factors for asthma (maternal history of allergic diseases, gender, number of older siblings, and 
smoking during pregnancy). The models of bacterial richness, Lactococcus and ever asthma were 
carefully tested for 25 additional confounding factors (for example dogs or cats ownership and 
staying indoors; attendance to day care; breastfeeding; mode of delivery; birth weight; maternal 
age; paternal allergic disease; maternal or paternal ducational level; house characteristics e.g. mold 
or moisture damage and ventilation system; and season of dust sampling), which have been 
described earlier.E1 None of these potential confounders changed the estimates of exposure by 
>10%, and thus were not included in the analyses. Due to skewed distributions and outliers, the 
highest 5% of relative abundances of 13 genera wereexcluded in the sensitivity analyses: the results 
were mostly the same or the estimates were even stro ge  (data not shown). The data were analyzed 
using SAS 9.3 for Windows. Plots were created by using ggplot2 in RStudio and box-plots and 
diagrams with Excel.    
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3 Results 
At the phylum level, Proteobacteria (36%) and Firmicutes (34%) had the highest relative 
abundances of the 30 phyla, which were detected in the floor dust, followed by Actinobacteria 
(18%) and Bacteroidetes (9%) (Figure E1).  
 
Correlations between relative abundance of genera and diversity indices 
Relative abundance of Lactococcus correlated negatively with the relative abundances of 12 genera 
(mostly r= -0.25) (Figure E2). Diversity indices were highly interco related (r=0.93), but were less 
correlated with the amounts of dust (mg/m2) or total bacterial qPCR. Correlation coefficients 
between the sum abundance of the 12 protective genera a d richness, Shannon diversity index, 
amounts of dust, total bacterial qPCR and endotoxin were 0.69, 0.58, 0.27, 0.08 and 0.27, 
respectively (Figure E2).    
 
Determinants for Lactococcus and the sum abundance of the 12 protective genera 
Houses that were newer (build in 1970 or after) and ha  mechanical exhaust ventilation (from 
kitchen/bathroom) had higher levels of Lactococcus (Table E5). In contrast, lower levels were 
observed in farm homes and homes that had a basement, or homes where dog(s) or cat(s) were kept 
mostly indoors. The determinants for higher levels of the sum abundance of the 12 protective 
genera were foundation type, heating with wood, dog ownership and frequent contact with horses 
during first trimester of pregnancy. On the other hand, newer houses (build 1970 or after), 
construction material and other ventilation system in the house than natural ventilation decreased 
the levels of the sum abundance of the 12 genera (Table E10).  
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Sensitivity analyses  
At the age of 3 years, majority (80.2%) of the children still lived in the same house where the dust 
sample was collected at the age of 2 months. When cildren (n=74, 19.8%), who had moved at least 
once before the age of 3 years and children who still lived in the same house, analyzed separately, 
the main results (asthma ever vs. Lactococcus, the sum abundance of the 12 protective genera and 
diversity indices) did not change.  
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